American Academy of Pediatrics (2005). 2005State Legislation Report. Available at: http:// search=%22state %20legislation %20thimero-sal %20map %22 (accessed 24 August 2006). Barquet, N. and Domingo, P. (1997). Smallpox: the triumph over the most terrible ministers of death. Annals of Internal Medicine 127(8), 635-642. Batson, A. (2005). The problems and promise of vaccine markets in developing countries.

Health Affairs 24(3), 691-693. Berndt, E.R. and Hurvitz, J.A. (2005). Vaccine advance-purchase agreements for low-

income countries: practical issues. Health Affairs 24(3), 653-665. Bland, J. and Clements, J. (1998). Protecting the world's children: the story of the WHO's immunization programme. World Health Forum 19, 162-173. Centers for Disease Control and Prevention (1997). Smallpox surveillance - worldwide.

Morbidity and Mortality Weekly Report 46(42), 990-994. Centers for Disease Control and Prevention. (1999a). Ten great public health achievements -

United States, 1900-1999. Morbidity and Mortality Weekly Report 48(12), 241-243. Centers for Disease Control and Prevention (1999b). Achievements in public health, 1900-1999. Impact of vaccines universally recommended for children - United States, 1990-1998. Morbidity and Mortality Weekly Report 48(12), 243-248. Centers for Disease Control and Prevention (2004a). Brief report: global polio eradication initiative strategic plan, 2004. Morbidity and Mortality Weekly Report 53(05), 107-108. Centers for Disease Control and Prevention (2004b). Progress toward measles elimination -region of the Americas, 2002-2003. Morbidity and Mortality Weekly Report 53(14), 304-306.

Centers for Disease Control and Prevention (2006). A Global Commitment to Lifelong Protection through Immunization: National Immunization Program Annual Report. Available at: (accessed 17 August 2006). Child Trends Data Bank (2006). Available at:

indicators/17Immunization.cfm trends (accessed 24 August 2006). Coleman, M.S., Sangrujee, N., Zhou, F. and Chu, S. (2005). Factors affecting US manufacturers' decisions to produce vaccines. Health Affairs 24(3), 635-642. Danzon, P. and Pereira, N.S. (2005). Why sole-supplier vaccine markets may be here to stay. Health Affairs 24(3), 694-700. Danzon, P.M., Pereira, N.S. and Tejwani, S.S. (2005). Vaccine supply: a cross-national perspective. Health Affairs 24(3), 706-717. Davis, M.M., Zimmerman, J.L., Wheeler, J.R.C. and Freed, G.L. (2002). Childhood vaccine purchase costs in the public sector: past trends, future expectations. American Journal of Public Health 92(12), 1982-1987.

Ehreth, J. (2003). The value of vaccination: a global perspective. Vaccine 21, 4105-4117.

Fedson, D.S. (2005). Preparing for pandemic vaccination: an international policy agenda for vaccine development. Journal of Public Health Policy 26, 4-29.

Feudtner, C. and Marcuse, E.K. (2001). Ethics and immunization policy: promoting dialogue to sustain consensus. Pediatrics 107(5), 1158-1164.

Foege, W.H. (1998). Confronting emerging infections: lessons from the smallpox eradication campaign. Emerging Infectious Diseases 4(3), 412-413.

Global Alliance for Vaccines and Immunization (2006). The GAVIAlliance Fact Sheet. Available at: 1.06.pdf (accessed 1 March 2006).

Global Polio Eradication Initiative (2006). The History. Available at: (accessed 7 March 2006).

Glynn, I. and Glynn, J. (2004). The Life and Death of Smallpox. New York: Cambridge University Press.

Hampton, T. (2004). Funding advances invigorate TB fight. Journal of the American Medical Association 291(21), 2529-2530.

Henderson, D.A. (1999). Eradication: lessons from the past. Morbidity and Mortality Weekly Report 48(SU01), 16-22.

Institute of Medicine (2004). Immunization Safety Review: Vaccines and Autism. New York: IOM.

Institut Pasteur (2006). The History of the Pasteur Institute. Available at: http://www. (accessed 1 March 2006).

Jones, M.M. (2005). Protecting Public Health in New York City: 200 Years of Leadership. New York: Bureau of Communications, Department of Health and Mental Hygiene. Available at: (accessed 1 March 2006).

Junod, S.W. (2002). Biologics Centennial: 100 Years of Biologic Regulation. Update. Rockville: FDA, Food and Drug Law Institute. Available at: history/makinghistory/100yearsofbiologics.html (accessed 1 March 2006).

Kane, M.A. (1998). Commentary: public perception and the safety of immunization. Vaccine 16, S73-75.

Keja, K., Chanc, C., Hayden, G. and Henderson, R.H. (1988). Expanded programme on immunization. World Health Stat Q 41(2), 59-63.

Leavell, B.S. (1977). Thomas Jefferson and smallpox vaccination. Transactions of the American Clinical and Climatological Association 138, 119-127.

Levine, M.M. (2004). New Generation Vaccines, 3rd edn. New York: Marcel Dekker.

Levine, M.M. and Levine, O.S. (1997). Influence of disease burden, public perception, and other factors on new vaccine development, implementation, and continued use. Lancet 350, 1386-1392.

Lieu, T.A., McGuire, T.G. and Hinman, A.R. (2005). Overcoming economic barriers to the optimal use of vaccines. Health Affairs 24(3), 666-679.

March of Dimes (2006). The March of Dimes Story. Available at: (accessed 1 March 2006).

McPhillips, H. and Marcuse, E.K. (2001). Vaccine safety. Current Problems in Pediatrics 31, 95-121.

Merck (2005). Merck Vaccines Play a Critical Role in Eliminating Health Threat from Rubella in the United States. Corporate News. Available at: newsroom/press_release/corporate/2005_0321.html (accessed 16 January 2006).

Milstien, J.B. (2004). Regulation of vaccines: strengthening the science base. Journal of Public Health Policy 25 (2), 173-189.

National Vaccine Advisory Committee (NVAC) (1997). United States vaccine research: a delicate fabric of public and private collaboration. Pediatrics 100, 1015-1020.

Offit, P.A. (2005a). The Cutter Incident: How America's First Polio Vaccine led to the Growing Vaccine Crisis. New Haven: Yale University Press.

Offit, P.A. (2005b). Why are pharmaceutical companies gradually abandoning vaccines? Health Affairs 24(3), 622-629.

Orenstein, W.A., Douglas, R.G., Rodewald, L.E. and Hinman, A.R. (2005). Immunizations in the United States: success, structure, and stress. Health Affairs 24(3), 599-610.

Plotkin, S.A. (2005). Why certain vaccines have been delayed or not developed at all. Health Affairs 24(3), 631-634.

Plotkin, S.A. and Orenstein, W.A. (2004). Vaccines, (4th edn). Philadelphia: Elsevier, Inc.

Program for Appropriate Technology in Health (PATH) (2005). New Gates Funding will Enable MVI and GSK Biologicals to Complete Development of World's Most Advanced Malaria Vaccine Candidate. Available at: (accessed 29 March 2006).

Shearley, A.J. (1999). The societal value of vaccination in developing countries. Vaccine 17(Suppl. 3), S109-112.

Smith, J.S. (1990). Patenting the Sun: Polio and the Salk Vaccine. New York: William Morrow and Company, Inc.

Stern, I.S. and Markel, H. (2005). The history of vaccines and immunization: familiar patterns, new challenges. Health Affairs 24(3), 611-621.

United Nations Children's Fund (UNICEF) (2005). Progress for Children: A Report Card on Immunization, No. 3. Available at: 2005n2/ (accessed 17 August 2006).

Wall Street Journal, New York, 26 April 2005.A1. Vaccine "Mosquirix" (available at:

Wilson, C.B. and Marcuse, E.K. (2001). Vaccine safety - vaccine benefits: science and the public's perception. Nature Reviews Immunology 1, 160-165.

World Health Organization (2005a). Immunization against disease of public health importance. WHO Fact Sheet No. 288. Available at: factsheets/fs288/en/index.html (accessed 16 January 2006).

World Health Organization (2005b). Wall Chart: Years of Life Lost to AIDS, Twenty Countries with the Highest Adult HIV Prevalence, 2000-2005. Department for Economic and Social Affairs/Population Division. Available at: population/publications/aidswallchart/chart2.jpg (accessed 28 August 2006).

Infectious diseases in the context of war, civil strife and social dislocation

0 0

Post a comment